An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management
Open accessThe DOI matches its Crossref record; 324 of the 325 references it cites were found in a registry or an index.
Abstract
This document is an international evidence-based guideline on the diagnosis and management of idiopathic pulmonary fibrosis, and is a collaborative effort of the American Thoracic Society, the European Respiratory Society, the Japanese Respiratory Society, and the Latin American Thoracic Association. It represents the current state of knowledge regarding idiopathic pulmonary fibrosis (IPF), and contains sections on definition and epidemiology, risk factors, diagnosis, natural history, staging and prognosis, treatment, and monitoring disease course. For the diagnosis and treatment sections, pragmatic GRADE evidence-based methodology was applied in a question-based format. For each diagnosis and treatment question, the committee graded the quality of the evidence available (high, moderate, low, or very low), and made a recommendation (yes or no, strong or weak). Recommendations were based on majority vote. It is emphasized that clinicians must spend adequate time with patients to discuss patients' values and preferences and decide on the appropriate course of action.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, all patients originally gathered from hospital register using ICD-10 codes were meticulously re-assessed and re-classified using the year 2011 criteria, and the cases representing some other type of ILDs were excluded [14].”
From Comparison of disease progression subgroups in idiopathic pulmonary fibrosis (2019) · cites this paper as [14]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“ILD still has a poor prognosis and the highest mortality rate during lung transplantation.”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [48]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Interstitial lung disease (ILD) remains an important indication for lung transplantation, and the number of patients with this disease is increasing.”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [48]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Idiopathic pulmonary fibrosis (IPF), characterized histopathologically and/or radiologically with a usual interstitial pneumonia (UIP) pattern, is the most common adult form of interstitial pneumonia of unknown origin [1].”
From Lung transplantation in idiopathic pulmonary fibrosis: a systematic review of the literature (2014) · cites this paper as [1]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The median survival time for patients with IPF is 2 to 3 years from diagnosis and the 5-year survival rate ranges between 30% and 50% [1,5-7].”
From Lung transplantation in idiopathic pulmonary fibrosis: a systematic review of the literature (2014) · cites this paper as [1]
Experimental — accuracy not yet measured
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Miller, M. R., Hankinson, J., Brusasco, V., Burgos, F., Casaburi, R., Coates, A., Crapo, R., Enright, P., van der Grinten, C. P. M., Gustafsson, P., et al. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00034805 · Cited by 15,627
ATS Statement: Guidelines for the Six-Minute Walk Test
(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.166.1.at1102 · Cited by 11,195
Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., & Thun, M. J. (2007) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.1.43 · Cited by 7,439
Interpretative strategies for lung function tests
Pellegrino, R., Viegi, G., Brusasco, V., Crapo, R. O., Burgos, F., Casaburi, R., Coates, A., van der Grinten, C. P. M., Gustafsson, P., Hankinson, J., et al. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00035205 · Cited by 5,945
Fleischner Society: Glossary of Terms for Thoracic Imaging
Hansell, D. M., Bankier, A. A., MacMahon, H., McLoud, T. C., Müller, N. L., & Remy, J. (2008) · Radiology · doi:10.1148/radiol.2462070712 · Cited by 4,198
Self-citation(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.2.ats01 · Cited by 4,196
Standardisation of the measurement of lung volumes
Wanger, J., Clausen, J. L., Coates, A., Pedersen, O. F., Brusasco, V., Burgos, F., Casaburi, R., Crapo, R., Enright, P., van der Grinten, C. P. M., et al. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00035005 · Cited by 2,768
Idiopathic Pulmonary Fibrosis: Diagnosis and Treatment: International Consensus Statement
(2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.2.ats3-00 · Cited by 2,628
Standardisation of the single-breath determination of carbon monoxide uptake in the lung
MacIntyre, N., Crapo, R. O., Viegi, G., Johnson, D. C., van der Grinten, C. P. M., Brusasco, V., Burgos, F., Casaburi, R., Coates, A., Enright, P., et al. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00034905 · Cited by 2,255
NOCTURNAL OXYGEN THERAPY TRIAL GROUP* (1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-3-391 · Cited by 2,218
Research works printed but not linked: 9
- Cochrane Handbook for Systematic Reviews of Interventions 5.0.2. Oxford: The Cochrane Collaboration, 2009. [online] 2009. [accessed 20 June 2010]; Available from: http://www.cochrane.org/resources/handbook/.
- Nadrous HF, Ryu JH, Douglas WW, Decker PA, Olson EJ. Impact of angiotensin-converting enzyme inhibitors and statins on survival in idiopathic pulmonary fibrosis. Chest 2004;126:438–446. [DOI] [PubMed] [Google Scholar]
- 2005, J Gastrointest Surg, 1053
- Marshall RP, Puddicombe A, Cookson WO, Laurent GJ. Adult familial cryptogenic fibrosing alveolitis in the UK. Thorax 2000;55:143–146. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gross TJ, Hunninghake GW. Idiopathic pulmonary fibrosis. N Engl J Med 2001;345:517–525. [DOI] [PubMed] [Google Scholar]
- Kondo A, Saiki S. Acute exacerbation in idiopathic interstitial pneumonia (IIP). In: Harasawa M, Fukuchi Y, Morinari H, editors. Interstitial pneumonia of unknown etiology. Tokyo: University of Tokyo Press; 1989. pp. 33–42.
- Flaherty KR, Colby TV, Toews GB, Travis WD, Flint A, Gay SE, Strawderman RL III, Jain A, Lynch JP III, Martinez FJ. Differential presence of fibroblastic foci in UIP patients with or without conntective tissue disease. Am J Respir Crit Care Med 2001;163:A983. [Google Scholar]
- Molina-Molina M, Badia JR, Marin-Arguedas A, Xaubet A, Santos MJ, Nicolas JM, Ferrer M, Torres A. Outcomes and clinical characteristics of patients with pulmonary fibrosis and respiratory failure admitted to an intensive care unit: a study of 20 cases. Med Clin (Barc) 2003;121:63–67. [DOI] [PubMed] [Google Scholar]
- Pitsiou G, Ioannis Trigonis I, Tsiata E, Kontou P, Manolakoglou N, Stanopoulos I, Mavrofridis E, Argyropoulou P. Outcome of patients with pulmonary fibrosis admitted to the ICU for acute respiratory failure. Eur Respir J Suppl 2006;28:E650. [Google Scholar]
Cited by
Items 101–200 of 1,060
(1997) · PubMed
Epidemiology of idiopathic pulmonary fibrosis
Ley, B., & Collard, H. (2013) · Clinical Epidemiology · doi:10.2147/clep.s54815 · Cited by 321
Self-citationIdiopathic pulmonary fibrosis: Epithelial-mesenchymal interactions and emerging therapeutic targets
Hewlett, J. C., Kropski, J. A., & Blackwell, T. S. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.03.021 · Cited by 321
Jacobs, S. S., Krishnan, J. A., Lederer, D. J., Ghazipura, M., Hossain, T., Tan, A.-Y. M., Carlin, B., Drummond, M. B., Ekström, M., Garvey, C., et al. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202009-3608st · Cited by 318
Self-citationRyerson, C. J., Hartman, T., Elicker, B. M., Ley, B., Lee, J. S., Abbritti, M., Jones, K. D., King, T. E., Ryu, J., & Collard, H. R. (2013) · Chest · doi:10.1378/chest.12-2403 · Cited by 315
Self-citationPulmonary rehabilitation for interstitial lung disease
Dowman, L., Hill, C. J., May, A., & Holland, A. E. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006322.pub4 · Cited by 315
Jenkins, R. G., Simpson, J. K., Saini, G., Bentley, J. H., Russell, A.-M., Braybrooke, R., Molyneaux, P. L., McKeever, T. M., Wells, A. U., Flynn, A., et al. (2015) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00048-x · Cited by 314
Self-citationThe Role of Immune and Inflammatory Cells in Idiopathic Pulmonary Fibrosis
Desai, O., Winkler, J., Minasyan, M., & Herzog, E. L. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00043 · Cited by 314
The Impact of Lung Cancer on Survival of Idiopathic Pulmonary Fibrosis
Tomassetti, S., Gurioli, C., Ryu, J. H., Decker, P. A., Ravaglia, C., Tantalocco, P., Buccioli, M., Piciucchi, S., Sverzellati, N., Dubini, A., et al. (2015) · Chest · doi:10.1378/chest.14-0359 · Cited by 314
Self-citationExploring Animal Models That Resemble Idiopathic Pulmonary Fibrosis
Tashiro, J., Rubio, G. A., Limper, A. H., Williams, K., Elliot, S. J., Ninou, I., Aidinis, V., Tzouvelekis, A., & Glassberg, M. K. (2017) · Frontiers in Medicine · doi:10.3389/fmed.2017.00118 · Cited by 314
Idiopathic pulmonary fibrosis: Current and future treatment
Glass, D. S., Grossfeld, D., Renna, H. A., Agarwala, P., Spiegler, P., DeLeon, J., & Reiss, A. B. (2022) · The Clinical Respiratory Journal · doi:10.1111/crj.13466 · Cited by 314
TRPV4 mediates myofibroblast differentiation and pulmonary fibrosis in mice
Rahaman, S. O., Grove, L. M., Paruchuri, S., Southern, B. D., Abraham, S., Niese, K. A., Scheraga, R. G., Ghosh, S., Thodeti, C. K., Zhang, D. X., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci75331 · Cited by 310
Stuart, B. D., Lee, J. S., Kozlitina, J., Noth, I., Devine, M. S., Glazer, C. S., Torres, F., Kaza, V., Girod, C. E., Jones, K. D., et al. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(14)70124-9 · Cited by 310
Self-citationPrevalence and prognosis of unclassifiable interstitial lung disease
Ryerson, C. J., Urbania, T. H., Richeldi, L., Mooney, J. J., Lee, J. S., Jones, K. D., Elicker, B. M., Koth, L. L., King, T. E., Wolters, P. J., et al. (2013) · European Respiratory Journal · doi:10.1183/09031936.00131912 · Cited by 310
Self-citationJacob, J., Bartholmai, B. J., Rajagopalan, S., Kokosi, M., Nair, A., Karwoski, R., Walsh, S. L. F., Wells, A. U., & Hansell, D. M. (2017) · European Respiratory Journal · doi:10.1183/13993003.01011-2016 · Cited by 309
Self-citationIdiopathic Pulmonary Fibrosis and Lung Cancer: Mechanisms and Molecular Targets
Ballester, B., Milara, J., & Cortijo, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030593 · Cited by 308
Sato, T., Teramukai, S., Kondo, H., Watanabe, A., Ebina, M., Kishi, K., Fujii, Y., Mitsudomi, T., Yoshimura, M., Maniwa, T., et al. (2014) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2013.09.050 · Cited by 307
Self-citationRole of matrix metalloproteinases in the pathogenesis of idiopathic pulmonary fibrosis
Pardo, A., Cabrera, S., Maldonado, M., & Selman, M. (2016) · Respiratory Research · doi:10.1186/s12931-016-0343-6 · Cited by 307
Self-citationThe Lung in Rheumatoid Arthritis: Focus on Interstitial Lung Disease
Spagnolo, P., Lee, J. S., Sverzellati, N., Rossi, G., & Cottin, V. (2018) · Arthritis & Rheumatology · doi:10.1002/art.40574 · Cited by 306
Nintedanib with Add-on Pirfenidone in Idiopathic Pulmonary Fibrosis. Results of the INJOURNEY Trial
Vancheri, C., Kreuter, M., Richeldi, L., Ryerson, C. J., Valeyre, D., Grutters, J. C., Wiebe, S., Stansen, W., Quaresma, M., Stowasser, S., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201706-1301oc · Cited by 305
Self-citationPrevalence and incidence of interstitial lung diseases in a multi-ethnic county of Greater Paris
Duchemann, B., Annesi-Maesano, I., Jacobe de Naurois, C., Sanyal, S., Brillet, P.-Y., Brauner, M., Kambouchner, M., Huynh, S., Naccache, J. M., Borie, R., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.02419-2016 · Cited by 304
Diagnostic yield of transbronchial cryobiopsy in interstitial lung disease: A randomized trial
Pajares, V., Puzo, C., Castillo, D., Lerma, E., Montero, M. A., Ramos‐Barbón, D., Amor‐Carro, O., Gil de Bernabé, A., Franquet, T., Plaza, V., et al. (2014) · Respirology · doi:10.1111/resp.12322 · Cited by 300
Blockade of IL-6 Trans Signaling Attenuates Pulmonary Fibrosis
Le, T.-T. T., Karmouty-Quintana, H., Melicoff, E., Le, T.-T. T., Weng, T., Chen, N.-Y., Pedroza, M., Zhou, Y., Davies, J., Philip, K., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302470 · Cited by 299
Air pollution exposure—the (in)visible risk factor for respiratory diseases
Bălă, G.-P., Râjnoveanu, R.-M., Tudorache, E., Motișan, R., & Oancea, C. (2021) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-13208-x · Cited by 298
Allen, R. J., Porte, J., Braybrooke, R., Flores, C., Fingerlin, T. E., Oldham, J. M., Guillen-Guio, B., Ma, S.-F., Okamoto, T., John, A. E., et al. (2017) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(17)30387-9 · Cited by 297
Lung transplantation for idiopathic pulmonary fibrosis
George, P. M., Patterson, C. M., Reed, A. K., & Thillai, M. (2019) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30502-2 · Cited by 297
Ley, B., Newton, C. A., Arnould, I., Elicker, B. M., Henry, T. S., Vittinghoff, E., Golden, J. A., Jones, K. D., Batra, K., Torrealba, J., et al. (2017) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(17)30216-3 · Cited by 296
Pirfenidone safety and adverse event management in idiopathic pulmonary fibrosis
Lancaster, L. H., de Andrade, J. A., Zibrak, J. D., Padilla, M. L., Albera, C., Nathan, S. D., Wijsenbeek, M. S., Stauffer, J. L., Kirchgaessler, K.-U., & Costabel, U. (2017) · European Respiratory Review · doi:10.1183/16000617.0057-2017 · Cited by 295
Self-citationAcute exacerbation of idiopathic pulmonary fibrosis associated with air pollution exposure
Johannson, K. A., Vittinghoff, E., Lee, K., Balmes, J. R., Ji, W., Kaplan, G. G., Kim, D. S., & Collard, H. R. (2014) · European Respiratory Journal · doi:10.1183/09031936.00122213 · Cited by 295
Self-citationRicheldi, L., Fernández Pérez, E. R., Costabel, U., Albera, C., Lederer, D. J., Flaherty, K. R., Ettinger, N., Perez, R., Scholand, M. B., Goldin, J., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(19)30262-0 · Cited by 293
Self-citationmiR-29 Inhibits Bleomycin-induced Pulmonary Fibrosis in Mice
Xiao, J., Meng, X.-M., Huang, X. R., Chung, A. C., Feng, Y.-L., Hui, D. S., Yu, C.-M., Sung, J. J., & Lan, H. Y. (2012) · Molecular Therapy · doi:10.1038/mt.2012.36 · Cited by 293
Chen, Z., Cao, M., Plana, M. N., Liang, J., Cai, H., Kuwana, M., & Sun, L. (2013) · Arthritis Care & Research · doi:10.1002/acr.21985 · Cited by 288
DePianto, D. J., Chandriani, S., Abbas, A. R., Jia, G., N'Diaye, E. N., Caplazi, P., Kauder, S. E., Biswas, S., Karnik, S. K., Ha, C., et al. (2015) · Thorax · doi:10.1136/thoraxjnl-2013-204596 · Cited by 287
Self-citationMethotrexate and rheumatoid arthritis associated interstitial lung disease
Juge, P., Lee, J. S., Lau, J., Kawano-Dourado, L. B., Rojas‐Serrano, J., Sebastiani, M., Koduri, G., Matteson, E. L., Bonfiglioli, K. R., Sawamura, M. V. Y., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.00337-2020 · Cited by 282
Self-citationEfficacy of Nintedanib in Idiopathic Pulmonary Fibrosis across Prespecified Subgroups in INPULSIS
Costabel, U., Inoue, Y., Richeldi, L., Collard, H. R., Tschoepe, I., Stowasser, S., & Azuma, A. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201503-0562oc · Cited by 280
Self-citationChambers, D. C., Enever, D., Ilic, N., Sparks, L., Whitelaw, K., Ayres, J., Yerkovich, S. T., Khalil, D., Atkinson, K. M., & Hopkins, P. M. A. (2014) · Respirology · doi:10.1111/resp.12343 · Cited by 278
Raghu, G., Brown, K. K., Collard, H. R., Cottin, V., Gibson, K. F., Kaner, R. J., Lederer, D. J., Martinez, F. J., Noble, P. W., Song, J. W., et al. (2017) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(16)30421-0 · Cited by 278
Self-citationDowman, L. M., McDonald, C. F., Hill, C. J., Lee, A. L., Barker, K., Boote, C., Glaspole, I., Goh, N. S. L., Southcott, A. M., Burge, A. T., et al. (2017) · Thorax · doi:10.1136/thoraxjnl-2016-208638 · Cited by 278
Macitentan for the treatment of idiopathic pulmonary fibrosis: the randomised controlled MUSIC trial
Raghu, G., Million-Rousseau, R., Morganti, A., Perchenet, L., Behr, J., & the MUSIC Study Group (2013) · European Respiratory Journal · doi:10.1183/09031936.00104612 · Cited by 277
Self-citationCharacterisation of patients with interstitial pneumonia with autoimmune features
Oldham, J. M., Adegunsoye, A., Valenzi, E., Lee, C., Witt, L., Chen, L., Husain, A. N., Montner, S., Chung, J. H., Cottin, V., et al. (2016) · European Respiratory Journal · doi:10.1183/13993003.01565-2015 · Cited by 275
Antoniou, K. M., Margaritopoulos, G. A., Tomassetti, S., Bonella, F., Costabel, U., & Poletti, V. (2014) · European Respiratory Review · doi:10.1183/09059180.00009113 · Cited by 274
Self-citationKhanna, D., Albera, C., Fischer, A., Khalidi, N., Raghu, G., Chung, L., Chen, D., Schiopu, E., Tagliaferri, M., Seibold, J. R., et al. (2016) · The Journal of Rheumatology · doi:10.3899/jrheum.151322 · Cited by 268
Self-citationGuenther, A., Krauss, E., Tello, S., Wagner, J., Paul, B., Kuhn, S., Maurer, O., Heinemann, S., Costabel, U., Barbero, M. A. N., et al. (2018) · Respiratory Research · doi:10.1186/s12931-018-0845-5 · Cited by 268
Self-citationRole of Nrf2 and Its Activators in Respiratory Diseases
Liu, Q., Gao, Y., & Ci, X. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/7090534 · Cited by 267
Interstitial Lung Disease in India. Results of a Prospective Registry
Singh, S., Collins, B. F., Sharma, B. B., Joshi, J. M., Talwar, D., Katiyar, S., Singh, N., Ho, L., Samaria, J. K., Bhattacharya, P., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201607-1484oc · Cited by 267
Self-citationThe therapy of idiopathic pulmonary fibrosis: what is next?
Somogyi, V., Chaudhuri, N., Torrisi, S. E., Kahn, N., Müller, V., & Kreuter, M. (2019) · European Respiratory Review · doi:10.1183/16000617.0021-2019 · Cited by 265
Automated quantification of radiological patterns predicts survival in idiopathic pulmonary fibrosis
Maldonado, F., Moua, T., Rajagopalan, S., Karwoski, R. A., Raghunath, S., Decker, P. A., Hartman, T. E., Bartholmai, B. J., Robb, R. A., & Ryu, J. H. (2014) · European Respiratory Journal · doi:10.1183/09031936.00071812 · Cited by 264
Self-citationPalliative care in interstitial lung disease: living well
Kreuter, M., Bendstrup, E., Russell, A.-M., Bajwah, S., Lindell, K., Adir, Y., Brown, C. E., Calligaro, G., Cassidy, N., Corte, T. J., et al. (2017) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(17)30383-1 · Cited by 264
Self-citationNintedanib plus Sildenafil in Patients with Idiopathic Pulmonary Fibrosis
Kolb, M., Raghu, G., Wells, A. U., Behr, J., Richeldi, L., Schinzel, B., Quaresma, M., Stowasser, S., & Martinez, F. J. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1811737 · Cited by 264
Self-citationAlways cleave up your mess: targeting collagen degradation to treat tissue fibrosis
McKleroy, W., Lee, T.-H., & Atabai, K. (2013) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00418.2012 · Cited by 261
Imaging Patterns Are Associated with Interstitial Lung Abnormality Progression and Mortality
Putman, R. K., Gudmundsson, G., Axelsson, G. T., Hida, T., Honda, O., Araki, T., Yanagawa, M., Nishino, M., Miller, E. R., Eiriksdottir, G., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201809-1652oc · Cited by 261
Progressive fibrosing interstitial lung diseases: current practice in diagnosis and management
Wijsenbeek, M., Kreuter, M., Olson, A., Fischer, A., Bendstrup, E., Wells, C. D., Denton, C. P., Mounir, B., Zouad-Lejour, L., Quaresma, M., et al. (2019) · Current Medical Research and Opinion · doi:10.1080/03007995.2019.1647040 · Cited by 261
Diagnosis of idiopathic pulmonary fibrosis
Choi, H. S. (2021) · Journal of the Korean Medical Association · doi:10.5124/jkma.2021.64.4.248 · Cited by 259
Physiology of the lung in idiopathic pulmonary fibrosis
Plantier, L., Cazes, A., Dinh-Xuan, A.-T., Bancal, C., Marchand-Adam, S., & Crestani, B. (2018) · European Respiratory Review · doi:10.1183/16000617.0062-2017 · Cited by 259
Progressive pulmonary fibrosis: an expert group consensus statement
Rajan, S. K., Cottin, V., Dhar, R., Danoff, S., Flaherty, K. R., Brown, K. K., Mohan, A., Renzoni, E., Mohan, M., Udwadia, Z., et al. (2023) · European Respiratory Journal · doi:10.1183/13993003.03187-2021 · Cited by 258
Self-citationHostettler, K. E., Zhong, J., Papakonstantinou, E., Karakiulakis, G., Tamm, M., Seidel, P., Sun, Q., Mandal, J., Lardinois, D., Lambers, C., et al. (2014) · Respiratory Research · doi:10.1186/s12931-014-0157-3 · Cited by 258
Galli, J. A., Pandya, A., Vega‐Olivo, M., Dass, C., Zhao, H., & Criner, G. J. (2017) · Respirology · doi:10.1111/resp.13024 · Cited by 257
Tracking Impact of Interstitial Lung Disease in Systemic Sclerosis in a Complete Nationwide Cohort
Hoffmann-Vold, A.-M., Fretheim, H., Halse, A.-K., Seip, M., Bitter, H., Wallenius, M., Garen, T., Salberg, A., Brunborg, C., Midtvedt, Ø., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201903-0486oc · Cited by 257
Tzouvelekis, A., Paspaliaris, V., Koliakos, G., Ntolios, P., Bouros, E., Oikonomou, A., Zissimopoulos, A., Boussios, N., Dardzinski, B., Gritzalis, D., et al. (2013) · Journal of Translational Medicine · doi:10.1186/1479-5876-11-171 · Cited by 255
Self-citationDiagnosis and Evaluation of Hypersensitivity Pneumonitis
Fernández Pérez, E. R., Travis, W. D., Lynch, D. A., Brown, K. K., Johannson, K. A., Selman, M., Ryu, J. H., Wells, A. U., Tony Huang, Y.-C., Pereira, C. A. C., et al. (2021) · Chest · doi:10.1016/j.chest.2021.03.066 · Cited by 253
Self-citationPulmonary Autotaxin Expression Contributes to the Pathogenesis of Pulmonary Fibrosis
Oikonomou, N., Mouratis, M.-A., Tzouvelekis, A., Kaffe, E., Valavanis, C., Vilaras, G., Karameris, A., Prestwich, G. D., Bouros, D., & Aidinis, V. (2012) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2012-0004oc · Cited by 250
Self-citationGlassberg, M. K., Minkiewicz, J., Toonkel, R. L., Simonet, E. S., Rubio, G. A., DiFede, D., Shafazand, S., Khan, A., Pujol, M. V., LaRussa, V. F., et al. (2017) · Chest · doi:10.1016/j.chest.2016.10.061 · Cited by 249
Behr, J., Kreuter, M., Hoeper, M. M., Wirtz, H., Klotsche, J., Koschel, D., Andreas, S., Claussen, M., Grohé, C., Wilkens, H., et al. (2015) · European Respiratory Journal · doi:10.1183/09031936.00217614 · Cited by 247
Self-citationCrestani, B., Huggins, J. T., Kaye, M., Costabel, U., Glaspole, I., Ogura, T., Song, J. W., Stansen, W., Quaresma, M., Stowasser, S., et al. (2019) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30339-4 · Cited by 247
Self-citationdu Bois, R. M., Albera, C., Bradford, W. Z., Costabel, U., Leff, J. A., Noble, P. W., Sahn, S. A., Valeyre, D., Weycker, D., & King, T. E. (2014) · European Respiratory Journal · doi:10.1183/09031936.00131813 · Cited by 246
Self-citationSalisbury, M. L., Myers, J. L., Belloli, E. A., Kazerooni, E. A., Martinez, F. J., & Flaherty, K. R. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201608-1675pp · Cited by 243
Self-citationMorisset, J., Johannson, K. A., Vittinghoff, E., Aravena, C., Elicker, B. M., Jones, K. D., Fell, C. D., Manganas, H., Dubé, B.-P., Wolters, P. J., et al. (2017) · CHEST · doi:10.1016/j.chest.2016.10.029 · Cited by 243
Self-citationIdiopathic Pulmonary Fibrosis: Clinically Meaningful Primary Endpoints in Phase 3 Clinical Trials
Raghu, G., Collard, H. R., Anstrom, K. J., Flaherty, K. R., Fleming, T. R., King, T. E., Martinez, F. J., & Brown, K. K. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201201-0006pp · Cited by 242
Self-citationAn Exome Sequencing Study to Assess the Role of Rare Genetic Variation in Pulmonary Fibrosis
Petrovski, S., Todd, J. L., Durheim, M. T., Wang, Q., Chien, J. W., Kelly, F. L., Frankel, C., Mebane, C. M., Ren, Z., Bridgers, J., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201610-2088oc · Cited by 242
Lysoglycerophospholipids in chronic inflammatory disorders: The PLA2/LPC and ATX/LPA axes
Sevastou, I., Kaffe, E., Mouratis, M.-A., & Aidinis, V. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2012.07.019 · Cited by 241
Yao, Y., Wang, Y., Zhang, Z., He, L., Zhu, J., Zhang, M., He, X., Cheng, Z., Ao, Q., Cao, Y., et al. (2016) · Molecular Therapy · doi:10.1038/mt.2016.36 · Cited by 239
Flow Cytometric Analysis of Myeloid Cells in Human Blood, Bronchoalveolar Lavage, and Lung Tissues
Yu, Y.-R. A., Hotten, D. F., Malakhau, Y., Volker, E., Ghio, A. J., Noble, P. W., Kraft, M., Hollingsworth, J. W., Gunn, M. D., & Tighe, R. M. (2016) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2015-0146oc · Cited by 239
Evans, C. M., Fingerlin, T. E., Schwarz, M. I., Lynch, D., Kurche, J., Warg, L., Yang, I. V., & Schwartz, D. A. (2016) · Physiological Reviews · doi:10.1152/physrev.00004.2016 · Cited by 238
Self-citationEndoplasmic reticulum stress in pulmonary fibrosis
Burman, A., Tanjore, H., & Blackwell, T. S. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.03.015 · Cited by 237
Scott, M. K. D., Quinn, K., Li, Q., Carroll, R., Warsinske, H., Vallania, F., Chen, S., Carns, M. A., Aren, K., Sun, J., et al. (2019) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30508-3 · Cited by 237
Transforming Growth Factor-β: Master Regulator of the Respiratory System in Health and Disease
Aschner, Y., & Downey, G. P. (2016) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2015-0391tr · Cited by 237
Future Directions in Idiopathic Pulmonary Fibrosis Research. An NHLBI Workshop Report
Blackwell, T. S., Tager, A. M., Borok, Z., Moore, B. B., Schwartz, D. A., Anstrom, K. J., Bar-Joseph, Z., Bitterman, P., Blackburn, M. R., Bradford, W., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201306-1141ws · Cited by 236
Self-citationVisca, D., Mori, L., Tsipouri, V., Fleming, S., Firouzi, A., Bonini, M., Pavitt, M. J., Alfieri, V., Canu, S., Bonifazi, M., et al. (2018) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30289-3 · Cited by 235
Self-citationNintedanib in patients with idiopathic pulmonary fibrosis and preserved lung volume
Kolb, M., Richeldi, L., Behr, J., Maher, T. M., Tang, W., Stowasser, S., Hallmann, C., & du Bois, R. M. (2017) · Thorax · doi:10.1136/thoraxjnl-2016-208710 · Cited by 235
Self-citationAhluwalia, N., Shea, B. S., & Tager, A. M. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201403-0509pp · Cited by 235
Morisset, J., Johannson, K. A., Jones, K. D., Wolters, P. J., Collard, H. R., Walsh, S. L. F., Ley, B., Antoniou, K. M., Assayag, D., Behr, J., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201710-1986oc · Cited by 234
Self-citationKnipe, R. S., Tager, A. M., & Liao, J. K. (2015) · Pharmacological Reviews · doi:10.1124/pr.114.009381 · Cited by 233
Jo, H. E., Glaspole, I., Grainge, C., Goh, N., Hopkins, P. M. A., Moodley, Y., Reynolds, P. N., Chapman, S., Walters, E. H., Zappala, C., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.01592-2016 · Cited by 233
Incidence, Prevalence, and Survival of Patients with Idiopathic Pulmonary Fibrosis in the UK
Strongman, H., Kausar, I., & Maher, T. M. (2018) · Advances in Therapy · doi:10.1007/s12325-018-0693-1 · Cited by 233
Recommendations for respiratory rehabilitation in adults with coronavirus disease 2019
Zhao, H.-M., Xie, Y.-X., & Wang, C. (2020) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000848 · Cited by 232
Interstitial Lung Disease in Anti-MDA5 Positive Dermatomyositis
Wu, W., Guo, L., Fu, Y., Wang, K., Zhang, D., Xu, W., Chen, Z., & Ye, S. (2021) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-020-08822-5 · Cited by 232
Maher, T. M., van der Aar, E. M., Van de Steen, O., Allamassey, L., Desrivot, J., Dupont, S., Fagard, L., Ford, P., Fieuw, A., & Wuyts, W. (2018) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30181-4 · Cited by 231
Walsh, S. L. F., Sverzellati, N., Devaraj, A., Keir, G. J., Wells, A. U., & Hansell, D. M. (2014) · Thorax · doi:10.1136/thoraxjnl-2013-203843 · Cited by 229
Self-citationMBD2 serves as a viable target against pulmonary fibrosis by inhibiting macrophage M2 program
Wang, Y., Zhang, L., Wu, G.-R., Zhou, Q., Yue, H., Rao, L.-Z., Yuan, T., Mo, B., Wang, F.-X., Chen, L.-M., et al. (2021) · Science Advances · doi:10.1126/sciadv.abb6075 · Cited by 227
Pulmonary fibrosis, part I: epidemiology, pathogenesis, and diagnosis
Meyer, K. C. (2017) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2017.1312346 · Cited by 227
Raghu, G., van den Blink, B., Hamblin, M. J., Brown, A. W., Golden, J. A., Ho, L. A., Wijsenbeek, M. S., Vasakova, M., Pesci, A., Antin-Ozerkis, D. E., et al. (2018) · JAMA · doi:10.1001/jama.2018.6129 · Cited by 227
Self-citationRyerson, C. J., Corte, T. J., Lee, J. S., Richeldi, L., Walsh, S. L. F., Myers, J. L., Behr, J., Cottin, V., Danoff, S. K., Flaherty, K. R., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201702-0400pp · Cited by 226
Self-citationDrake, T. M., Docherty, A. B., Harrison, E. M., Quint, J. K., Adamali, H., Agnew, S., Babu, S., Barber, C. M., Barratt, S., Bendstrup, E., et al. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202007-2794oc · Cited by 226
Self-citationCottin, V., Selman, M., Inoue, Y., Wong, A. W., Corte, T. J., Flaherty, K. R., Han, M. K., Jacob, J., Johannson, K. A., Kitaichi, M., et al. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202206-1041st · Cited by 226
Self-citationPredicting survival in newly diagnosed idiopathic pulmonary fibrosis: a 3-year prospective study
Mura, M., Porretta, M. A., Bargagli, E., Sergiacomi, G., Zompatori, M., Sverzellati, N., Taglieri, A., Mezzasalma, F., Rottoli, P., Saltini, C., et al. (2012) · European Respiratory Journal · doi:10.1183/09031936.00106011 · Cited by 225
Target inhibition of galectin-3 by inhaled TD139 in patients with idiopathic pulmonary fibrosis
Hirani, N., MacKinnon, A. C., Nicol, L., Ford, P., Schambye, H., Pedersen, A., Nilsson, U. J., Leffler, H., Sethi, T., Tantawi, S., et al. (2021) · European Respiratory Journal · doi:10.1183/13993003.02559-2020 · Cited by 220
Role of interleukins in the pathogenesis of pulmonary fibrosis
She, Y. X., Yu, Q. Y., & Tang, X. X. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00437-9 · Cited by 219
Antacid therapy and disease outcomes in idiopathic pulmonary fibrosis: a pooled analysis
Kreuter, M., Wuyts, W., Renzoni, E., Koschel, D., Maher, T. M., Kolb, M., Weycker, D., Spagnolo, P., Kirchgaessler, K.-U., Herth, F. J. F., et al. (2016) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(16)00067-9 · Cited by 218
Self-citationOccupational hypersensitivity pneumonitis: an EAACI position paper
Quirce, S., Vandenplas, O., Campo, P., Cruz, M. J., Frederic de, B. L. A. Y., Koschel, D., Moscato, G., Pala, G., Raulf, M., Sastre, J., et al. (2016) · Allergy · doi:10.1111/all.12866 · Cited by 218
Johannson, K. A., Marcoux, V. S., Ronksley, P. E., & Ryerson, C. J. (2016) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201606-461sr · Cited by 217
Metadata
- Authors
- Raghu, G., Collard, H. R., Egan, J. J., Martinez, F. J., Behr, J., Brown, K. K., Colby, T. V., Cordier, J.-F., Flaherty, K. R., Lasky, J. A., Lynch, D. A., Ryu, J. H., Swigris, J. J., Wells, A. U., Ancochea, J., Bouros, D., Carvalho, C., Costabel, U., Ebina, M., Hansell, D. M., Johkoh, T., Kim, D. S., King, T. E., Kondoh, Y., Myers, J., Müller, N. L., Nicholson, A. G., Richeldi, L., Selman, M., Dudden, R. F., Griss, B. S., Protzko, S. L., & Schünemann, H. J.
- Affiliations
- University of Washington (US)
- University of California, San Francisco (US)
- Mater Misericordiae University Hospital (IE)
- Ludwig-Maximilians-Universität München (DE)
- Mayo Clinic (US)
- University of Michigan (US)
- Tulane University (US)
- University of Colorado Boulder (US)
- National Jewish Health (US)
- Royal Brompton Hospital (GB)
- Hospital Universitario de La Princesa (ES)
- University Hospital of Alexandroupolis (GR)
- Universidade de São Paulo (BR)
- Tohoku University (JP)
- Royal Brompton & Harefield NHS Foundation Trust (GB)
- The University of Osaka (JP)
- University of Ulsan (KR)
- University of Modena and Reggio Emilia (IT)
- Instituto Nacional de Enfermedades Respiratorias (MX)
- ORCID
- Raghu, Ganesh
- Collard, Harold R.
- Colby, Thomas V.
- Lasky, Joseph A.
- Lynch, David A.
- Ryu, Jay H.
- Swigris, Jeffrey J.
- Wells, Athol U.
- Ancochea, Julio
- Bouros, Demosthenes
- Carvalho, Carlos
- Costabel, Ulrich
- Johkoh, Takeshi
- King, Talmadge E.
- Kondoh, Yasuhiro
- Myers, Jeffrey
- Nicholson, Andrew G.
- Richeldi, Luca
- Selman, Moisés
- Schünemann, Holger J.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-03
- Volume
- 183
- Issue
- 6
- Pages
- 788-824
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- PMC
- PMC5450933
- OpenAlex
- W2167383172
- Cited by
- 7,186
- References
- 325
- Citations by year
- 2026: 187 · 2025: 307 · 2024: 436 · 2023: 432 · 2022: 522 · 2021: 640 · 2020: 607 · 2019: 596 · 2018: 607 · 2017: 605 · 2016: 569 · 2015: 531 · 2014: 426 · 2013: 370 · 2012: 256
- FWCI
- 304.18
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- American Journal of Respiratory and Critical Care Medicine (publishedVersion, public-domain)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- ePrints Soton (University of Southampton) (submittedVersion)
- IRIS UNIMORE (University of Modena and Reggio Emilia) (submittedVersion, cc-by)
- Funders
- National Heart, Lung, and Blood Institute (K23HL092227)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
- Keywords
- idiopathic pulmonary fibrosis, diagnosis, management, natural history (disease), staging, prognosis, risk factors, treatment, disease surveillance, GRADE
- MeSH terms
- Europe, Humans, International Cooperation, Japan, Latin America, Societies, Medical, United States, Evidence-Based Medicine, Idiopathic Pulmonary Fibrosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.